About Orgyn Laboratories
Orgyn Laboratories is a company based in Delhi (India) founded in 2013. It operates as a B2B. The company has 11 employees. Orgyn Laboratories operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
- Headquarter Delhi, India
- Employees 11
- SectorsHealthcare
- Website orgynlabs.com
- Legal Name Orgyn Laboratories Private Limited
- Date of Incorporation 13 May, 2002
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹8.59 Cr
FY 2025 · +18% YoY
- Net Profit₹31.5 Lakh
FY 2025 · 4% margin
- EBITDA₹51.1 Lakh
FY 2025 · 6% margin
- Employee Count11
Associated legal entities of Orgyn Laboratories
Orgyn Laboratories operates through Orgyn Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Orgyn Laboratories Private Limited CIN U51397DL2002PTC115595 | Active | 13 May 2002 | New Delhi, Delhi | ₹8.6 Cr | 11 | 2 | View details |
Board of directors of Orgyn Laboratories Private Limited (Orgyn Laboratories)
Orgyn Laboratories Private Limited is the primary company behind Orgyn Laboratories. The board of Orgyn Laboratories Private Limited currently have 2 directors; the longest-serving is Meeta Bhatia, appointed in 2002.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Meeta Bhatia DIN 03227632 | Director | 13 May 2002 | 24 yrs 4 mo | Orgyn Laboratories Private Limited |
| Sunil Bhatia DIN 03227767 | Director | 13 May 2002 | 24 yrs 4 mo | Orgyn Laboratories Private Limited |
Financials of Orgyn Laboratories
Figures of Orgyn Laboratories Private Limited, the primary company behind Orgyn Laboratories, for FY 2025. Revenue was ₹8.59 Cr (+18% year on year). Net profit was ₹31.5 Lakh (4% margin). EBITDA was ₹51.1 Lakh (6% margin). Revenue has grown at a compounded annual rate of -1% over three years and +9% over five years.
- ₹8.59 CrRevenue · FY 2025 · +18% YoY
- ₹31.5 LakhNet profit · 4% margin
- ₹51.1 LakhEBITDA · 6% margin
- ₹1 LakhPaid-up capital
- 11Employees (provident fund records)
- -1%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Orgyn Laboratories Private Limited are on its company page.
Detailed financial statements for Orgyn Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Orgyn Laboratories
Orgyn Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $11.53M | 161 | Provider of medical equipment, devices, and drugs distribution services | |
| mahaveermedi.com | 2016 | Bengaluru, India | – | 588 | Serves as a distributor of a wide range of pharmaceutical drugs. | |
| dipnapharmachem.com | 2011 | Ahmedabad, India | – | – | Distributor of pharmaceutical raw materials |
Detailed competitors of Orgyn Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Orgyn Laboratories
10 companies that operate in the same segment as Orgyn Laboratories (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Orgyn Laboratories
Orgyn Laboratories was founded in 2013.
Orgyn Laboratories is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Orgyn Laboratories has 11 employees.
The primary company behind Orgyn Laboratories, Orgyn Laboratories Private Limited, reported revenue of ₹8.59 Cr for FY 2025, up 18% year on year.
Orgyn Laboratories, founded in 2013 in Delhi, India, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and healthcare products. Develops and manufactures a range of healthcare products as a pharmaceutical company. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Orgyn Laboratories's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.
Orgyn Laboratories operates through Orgyn Laboratories Private Limited.
The legal entities of Orgyn Laboratories currently have 2 directors, including Meeta Bhatia, Sunil Bhatia.